Cargando…
FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost‐Effectiveness Analysis
POLICY POINTS: The World Health Organization has recommended sodium reduction as a “best buy” to prevent cardiovascular disease (CVD). Despite this, Congress has temporarily blocked the US Food and Drug Administration (FDA) from implementing voluntary industry targets for sodium reduction in process...
Autores principales: | COLLINS, BRENDAN, KYPRIDEMOS, CHRIS, PEARSON‐STUTTARD, JONATHAN, HUANG, YUE, BANDOSZ, PIOTR, WILDE, PARKE, KERSH, ROGAN, CAPEWELL, SIMON, MOZAFFARIAN, DARIUSH, WHITSEL, LAURIE P., MICHA, RENATA, O'FLAHERTY, MARTIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739614/ https://www.ncbi.nlm.nih.gov/pubmed/31332837 http://dx.doi.org/10.1111/1468-0009.12402 |
Ejemplares similares
-
Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis
por: Pearson-Stuttard, Jonathan, et al.
Publicado: (2018) -
Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: A modelling study
por: Pearson-Stuttard, Jonathan, et al.
Publicado: (2017) -
The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities in the United States
por: Peñalvo, José L., et al.
Publicado: (2017) -
Estimating the health and economic effects of the voluntary sodium reduction targets in Brazil: microsimulation analysis
por: Nilson, Eduardo Augusto Fernandes, et al.
Publicado: (2021) -
Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options
por: Kypridemos, Chris, et al.
Publicado: (2016)